Chemoinformaics analysis of 2-((3,3-Dimethyloxiran-2-yl)methyl)-3-methylfuran
Molecular Weight | 166.22 | nRot | 2 |
Heavy Atom Molecular Weight | 152.108 | nRig | 8 |
Exact Molecular Weight | 166.099 | nRing | 2 |
Solubility: LogS | -2.102 | nHRing | 2 |
Solubility: LogP | 2.529 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
No. of Oxygen atom | 2 | No. of Arom Bond | 5 |
nHA | 2 | APOL | 27.6391 |
nHD | 0 | BPOL | 17.5169 |
QED | 0.63 |
Synth | 3.487 |
Natural Product Likeliness | 2.1 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.003 |
HIA | 0.005 |
CACO-2 | -4.386 |
MDCK | 0.0000346 |
BBB | 0.272 |
PPB | 0.902315 |
VDSS | 2.528 |
FU | 0.142651 |
CYP1A2-inh | 0.185 |
CYP1A2-sub | 0.301 |
CYP2c19-inh | 0.302 |
CYP2c19-sub | 0.81 |
CYP2c9-inh | 0.148 |
CYP2c9-sub | 0.199 |
CYP2d6-inh | 0.011 |
CYP2d6-sub | 0.837 |
CYP3a4-inh | 0.028 |
CYP3a4-sub | 0.417 |
CL | 11.799 |
T12 | 0.457 |
hERG | 0.022 |
Ames | 0.016 |
ROA | 0.068 |
SkinSen | 0.087 |
Carcinogencity | 0.571 |
EI | 0.563 |
Respiratory | 0.961 |
NR-Aromatase | 0.01 |
Antiviral | No |
Prediction | 0.898724 |